NEW YORK (GenomeWeb News) – Caris Life Sciences today announced a distribution deal with IPS Genomix to provide patients access to Caris' tumor profiling service in certain Middle Eastern and African markets.

Caris' service, called Molecular Intelligence, uses multiple technologies, including immunohistochemistry, FISH/CISH, PCR, and next-generation sequencing, to provide actionable information to clinicians to develop a treatment plan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.